MRSN Crosses Above Average Analyst Target
September 15, 2020 at 10:14 AM EDT
In recent trading, shares of Mersana Therapeutics Inc (MRSN) have crossed above the average analyst 12-month target price of $23.40, changing hands for $24.17/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..